Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 979-986

  Boudreault, Alexandre A ^a,b   Xie, Hu ^a   Leisenring, Wendy ^a   Englund, Janet ^c   Corey, Lawrence ^a   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Antiviral; Corticosteroid; Hematopoietic cell transplant; Influenza; Outcome

Indexed keywords

AMANTADINE; BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; METHYLPREDNISOLONE PLUS PREDNISONE; OSELTAMIVIR; RIMANTADINE; UNCLASSIFIED DRUG; ZANAMIVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOXEMIA; INFLUENZA; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; TREATMENT DURATION; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS SHEDDING;

ADRENAL CORTEX HORMONES; ADULT; ANOXIA; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; CYTOKINES; DISEASE PROGRESSION; DRUG EVALUATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; POSTOPERATIVE COMPLICATIONS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRUS SHEDDING; YOUNG ADULT;

EID: 79958735608     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.09.014     Document Type: Article

References (35)

1. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008, 143:455-467.
2. Chemaly R.F., Ghosh S., Bodey G.P., et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006, 85:278-287.
3. Kim Y.J., Boeckh M., Englund J.A. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007, 28:222-242.
4. Nichols W.G., Guthrie K.A., Corey L., Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004, 39:1300-1306.
5. Weinstock D.M., Eagan J., Malak S.A., et al. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2000, 21:730-732.
6. Whimbey E., Elting L.S., Couch R.B., et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994, 13:437-440.
7. Carter M.J. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol 2007, 56:875-883.
8. Chan M.C., Cheung C.Y., Chui W.H., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005, 6:135.
9. Jamaleddine G., Kramer M., Zein J. Steroid use in acute lung injury/acute respiratory distress syndrome: what about the acute lung injury from H1N1?. Crit Care Med 2009, 37:2996.
10. Quispe-Laime A.M., Bracco J.D., Barberio P.A., et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intens Care Med 2010, 36:33-41.
11. Ottolini M., Blanco J., Porter D., Peterson L., Curtis S., Prince G. Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol 2003, 36:290-294.
12. Lee N., Chan P.K., Hui D.S., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009, 200:492-500.
13. Nichols W.G., Corey L., Gooley T., Davis C., Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001, 98:573-578.
14. Torres H.A., Aguilera E.A., Mattiuzzi G.N., et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica 2007, 92:1216-1223.
15. Hayden F.G., Osterhaus A.D., Treanor J.J., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997, 337:874-880.
16. Doyle W.J., Skoner D.P., Alper C.M., et al. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis 1998, 177:1260-1265.
17. Hayden F.G., Treanor J.J., Fritz R.S., et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999, 282:1240-1246.
18. Johny A.A., Clark A., Price N., Carrington D., Oakhill A., Marks D.I. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Bone Marrow Transplant 2002, 29:113-115.
19. Khanna N., Steffen I., Studt J.D., et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009, 11:100-105.
20. Machado C.M., Boas L.S., Mendes A.V., et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004, 34:111-114.
21. Kuypers J., Wright N., Ferrenberg J., et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 2006, 44:2382-2388.
22. Hockenbery D.M., Cruickshank S., Rodell T.C., et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood 2007, 109:4557-4563.
23. Chien J.W., Sakai M., Gooley T.A., Schoch H.G., McDonald G.B. Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from 2 randomized trials. Bone Marrow Transplant 2010, 45:317-324.
24. McDonald G.B. Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation. Expert Opin Investig Drugs 2007, 16:1709-1724.
25. Taplitz R., Espinosa-Aguilar L., Green J., et al. Novel H1N1 influenza in hematopoietic stem cell transplant recipients: two center's experience. Biol Blood Marrow Transplant 2010, [Epub ahead of print].
26. Hien N.D., Ha N.H., Van N.T., et al. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 2009, 15:19-23.
27. Li J., Xu Y., Chen Y.Q., et al. [Relationship between clinical features and prognosis of highly pathogenic avian influenza A/H5N1 infection in humans in mainland China]. Zhonghua Jie He He Hu Xi Za Zhi 2009, 32:335-341.
28. Liem N.T., Tung C.V., Hien N.D., et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009, 48:1639-1646.
29. Kuypers J., Campbell A.P., Cent A., Corey L., Boeckh M. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009, 11:298-303.
30. Ginocchio C.C., Zhang F., Manji R., et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009, 45:191-195.
31. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:826-829.
32. Peck A.J., Englund J.A., Kuypers J., et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007, 110:1681-1688.
33. Briel M., Bucher H.C., Boscacci R., Furrer H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database Syst Rev 2006, 3:CD006150.
34. Whitley R.J., Weiss H., Gnann J.W., et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996, 125:376-383.
35. van de Beek D., de Gans J., McIntyre P., Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007, CD004405.